Amneal Recalls Methylergonovine Maleate Tablets Due to Foreign Tablet Presence
Amneal Pharmaceuticals is recalling specific lots of Methylergonovine Maleate tablets because a Promethazine tablet was found in a bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class III recall, which is defined as unlikely to cause adverse health consequences. The hazard is a foreign object (wrong tablet) rather than a high-risk pathogen or structural defect, fitting the Moderate category for minor labeling or contamination issues without reported serious injury.
Plain-English summary
Amneal Pharmaceuticals, Inc. is recalling Methylergonovine Maleate USP 0.2 mg Tablets in 12-count and 28-count bottles. The recall involves Lot # BA10619A (12-count) and Lot # BA10619B (28-count), both with an expiration date of 07/2020. The total quantity affected is 2,256 bottles of the 12-count version and 240 bottles of the 28-count version.
The recall was initiated due to the presence of a foreign tablet; specifically, one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets. The product was distributed to three major distributors, who may have further distributed the product nationwide.
Consumers should check their medication for the specific lot numbers and expiration dates listed above. If they possess the affected product, they should stop using it and contact their healthcare provider or the recalling firm for instructions on return or replacement.
The recalled product
- Product
- Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 count bottles (NDC 69238-1605-08)
- Manufacturer
- Amneal Pharmaceuticals, Inc.
- Category
- Drug — Tablets
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- a) Lot # BA10619A
- b) Lot # BA10619B
- exp. date 07/2020
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Amneal Pharmaceuticals, Inc.
See all →- SevereAmneal Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-18
- SevereAmneal Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-18
- SevereAmneal Recalls Ranitidine Syrup Due to NDMA Impurity
FDA (Drugs) · 2019-12-18
- SevereAmneal Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-18
- SevereAmneal Recalls Ranitidine Tablets Due to NDMA Impurity
FDA (Drugs) · 2019-12-18
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02